Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued on ...
RBC Capital analyst Leonid Timashev maintained a Hold rating on Design Therapeutics (DSGN – Research Report) today and set a price target of ...
Carmell announced a comprehensive corporate rebranding initiative aimed at better aligning the Company’s market and investor facing image with ...
The federal and Alberta governments are ushering in new support for Jasper as the mountain town continues to rebuild from last summer’s devastating wildfires. The federal government says $2 ...
Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...
DALLAS, March 5, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular ...
After hours: March 7 at 7:53:59 PM EST ...
After hours: 7:53:59 pm GMT-5 Loading Chart for JSPR ...
Roche Holding AG Akt 0.25% CHF244.62B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback